Repurposing drugs against Alzheimer’s disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?

Therapeutic approaches providing effective medication for Alzheimer’s disease (AD) patients after disease onset are urgently needed. Previous studies in AD mouse models and in humans suggested that physical exercise or changed lifestyle can delay AD-related synaptic and memory dysfunctions when trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Leßmann, Volkmar, Kartalou, Georgia-Ioanna, Endres, Thomas, Pawlitzki, Marc, Gottmann, Kurt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Neurology and Preclinical Neurological Studies - Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374694/
https://www.ncbi.nlm.nih.gov/pubmed/37014414
http://dx.doi.org/10.1007/s00702-023-02618-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374694/
https://www.ncbi.nlm.nih.gov/pubmed/37014414
http://dx.doi.org/10.1007/s00702-023-02618-5

Ejemplares similares